Clinical Performance and Safety Investigation of ENDOmetrial Washing MEdical DEvice Forielle

Inclusion Criteria: * All infertile women treated with intracytoplasmic sperm injection (ICSI)/Fertilization in Vitro and Embryo Transfer (FIVET) * Less than or equal to (\<=) 1 previous failed embryo transfer * Eumenorrheic normo-gonadotropic women * Basal follicle-stimulating hormone (FSH) \<=12 International unit per liter (IU/L) * Anti-mullerian hormone (AMH) greater than (\>) 1.1 nanogram per milliliter (ng/mL) * Ovarian Reserve: number of antral follicles 2 millimeter (mm) between 6 \<= antral follicle count (AFC) \<= 16 * Follicles \> 16 mm at the triggering day between 5-14 * Body Mass Index (BMI) between 18 \<= BMI \<= 27 kilogram per meter square (kg/m\^2) * Indication for Fresh Embryo transfer * Normal uterine cavity on ultrasound exam (e.g., no presence of hydrosalpinx) * Undergoing Assisted Reproductive Technique (ART) and oocyte maturation by human chorionic gonadotropin (HCG) triggering * Progesterone (P4) serum level at the HCG triggering day \<= 1.5 ng/mL (Day O/Randomization) * Estradiol (E2) \<= 3000 picogram/milliliter (pg/mL) at the human chorionic gonadotropin (HCG) triggering day (Day 0/Randomization) * Subjects must have read and signed the Informed Consent Form prior to study-specific-procedures not part of standard of care * Other protocol defined inclusion criteria could apply Exclusion Criteria: * Clinically significant systemic disease (such as diabetes, metabolic syndrome, immunological diseases, diagnosed thrombophilia, porphyria, or any other medical condition requiring the use of low-molecular weight heparin therapy) * Polycystic ovary syndrome (PCOS) according to Rotterdam Consensus Criteria (European Society of Human Reproduction and Embryology \[ESHRE\]/American Society for Reproductive Medicine \[ASRM\], 2003) * Poor ovarian response (POR) according to the European Society of Human Reproduction and Embryology (ESHRE) Criteria * RIF (repeated implantation failure), defined as greater than or equals to (\>=) 2 previous failed embryo transfers * Endometriosis III-IV stage or adenomyosis * Clinically significant findings on exam or ultrasound, such as salpingitis, hydrosalpynx or evidence of ovarian cysts * Known hypersensitivity to any of the components of the solution * Known hypersensitivity to vaginal progesterone or its excipients * Other protocol defined exclusion criteria could apply